Cannabis Strategic Ventures (OTC: NUGS) this morning
announced that it has signed a definitive agreement to acquire the Fitamins CBD
brand. Per the terms of the agreement, Fitamins will distribute its vitamin and
hemp derived CBD formulations to its network of 600+ wholesalers catered to the
Asian-American market. Fitamins will also produce a proprietary CBD product as
part of Cannabis Strategic’s brand portfolio, primarily targeting the United
States’ distribution networks first and ultimately growing into other Asian
markets that have legalized CBD products. “We have selected Fitamins because of
its substantial distribution network and because of the import/export and
marketing channels that Fitamins already possesses, giving it a distinct
advantage once the brand comes online this next quarter,” Cannabis Strategic
Ventures CEO Simon Yu stated in the news release. “The Fitamins team includes
two principles who have proven track records with developing and selling
multi-million dollar brands in the Asian Nutraceuticals market along with
significant resources including ownership of multiple “as seen on TV” local and
DirecTV channel segments.”
To view the full press release, visit http://ibn.fm/BjU1S
About Cannabis Strategic Ventures, Inc.
Cannabis Strategic Ventures is based in Los Angeles and is
focused on supporting entrepreneurial growth within the fast-growing legal
cannabis sector. The company recently completed a name and symbol change from
Cascade Energy, Inc. Cannabis Strategic Ventures offers outsourced personnel
solutions that are tailor-made to match the growth dynamics of cannabis
cultivators, manufacturers, dispensaries, and other cannabis marketplace
participants. Cannabis Strategic Ventures is publicly traded on the OTC Markets
with the stock symbol NUGS. For more information, visit the company’s website
at www.CannabisStrategic.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
